Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - COST OF REVENUE
Cost of Revenue ITCI - Intra-Cellular Therapies, Inc.
33.7 M
LAST VALUE
104.94%
2 YEAR CAGR
146.78%
5 YEAR CAGR
3.90%
10 YEAR CAGR